Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anabolic Agents and Diet in Severely Burned Patients
NCT00673309Phase 3Completed
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Jul 2000
- Primary completion
- Apr 2011
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised trial of somatropin, regular human insulin, oxandrolone, propranolol, Premiplex and 1 more in burn injury (10 arms), sponsored by The University of Texas Medical Branch at Galveston. Primary endpoint: Decrease Hypermetabolism as Measured by Stable Isotope Infusion Study. Started Jul 2000; status: completed.
02
Drugs
somatropinregular human insulinoxandrolonepropranololPremiplex
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT00673309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00673309.